News & Events: Press Releases

ARCION THERAPEUTICS' TOPICAL GEL CANDIDATE ARC-4558 DEMONSTRATES SIGNIFICANT PAIN REDUCTION IN PHASE 2b TRIAL FOR PAINFUL DIABETIC NEUROPATHY

07/20/2009

Download PDF
ARCION THERAPEUTICS' TOPICAL PAIN CANDIDATE, ARC-4558, SIGNIFICANTLY REDUCES PAIN CAUSED BY DIABETIC NEUROPATHY

05/07/2009 - Clinical Data Presented at American Pain Society Annual Meeting.
Download PDF
ARCION THERAPEUTICS RAISES $8.8 MILLION "A" ROUND

01/09/2007 - Start-up's Breakthrough Work with Topical Clonidine Gel Has Potential to Improve Treatment for Neuropathic Pain.
Download PDF